國際間科學專家利益衝突管理規範趨向--以美、歐藥品審查機構科學諮詢委員會專家利益衝突解決政策與機制為例

To ensure the government founding will achieve the expected success, conduct the domestic biomedical industry to step forward with the decided industrial policy and orientation, and the promoted important biopharmaceutical research project will not be affected by unexpected obstacle. Therefore, the ... View More